University of Iowa Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title

Randomized, Phase II Study of MK-3475 versus Chemotherapy in Patients with Advanced Melanoma

Description

Participants in this research sub-study must initially take part in the main research study "Randomized, Phase II Study of MK-3475 versus Chemotherapy in Patients with Advanced Melanoma." The purpose of the substudy is to find out more about what causes disease and the differences in the way people respond to drug therapies. The study consists of providing blood samples, additional biological samples such as left over tumor biopsy or archival tumor tissue samples collected during the main study.

Start Date
March 8, 2013
End Date
October 4, 2013
Gender Preference
None
Age Group
0 - 99 years
Principal Investigator
Mohammed Milhem, MD
Contact Info

Melanie Frees, 319-356-1228

Department
Department or Field of Study
Keywords
cancer ; chemotherapy ; IRB#201208516 ; melanoma ; milhem ; MK-3475 ; pediatric ; phase II ; phase two ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.